![Daniela Oniciu](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Daniela Carmen Oniciu is the founder of Creative Pharma Advisors LLC.
She worked as an Associate Director-Chemistry at Pfizer Inc. from 2004 to 2008.
Prior to that, she was a Senior Director-Chemical Research & Development at Esperion Therapeutics, Inc. from 2001 to 2004.
From 2005 to 2014, she held the position of Senior Director-Chemistry at ABIONYX Pharma SA. Later, she served as the Vice President-Preclinical Research & Development at Gemphire Therapeutics, Inc. from 2014 to 2018.
In addition to her former jobs, she also worked as the Chief Operating Officer at BioSavita, Inc. and as the Head-Research & Development at Ocuphire Pharma, Inc. Dr. Oniciu obtained her graduate and doctorate degrees from Politehnica University of Bucharest.
Anciens postes connus de Daniela Oniciu
| Sociétés | Poste | Fin |
|---|---|---|
| OPUS GENETICS, INC. | Directeur Technique/Scientifique/R&D | 31/12/2023 |
| METAVIA INC. | Directeur Technique/Scientifique/R&D | 01/11/2018 |
| ABIONYX PHARMA SA | Corporate Officer/Principal | 01/02/2014 |
| PFIZER INC. | Corporate Officer/Principal | 01/02/2008 |
| ESPERION THERAPEUTICS, INC. | Corporate Officer/Principal | 01/01/2004 |
Formation de Daniela Oniciu
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
64
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Esperion Therapeutics, Inc.
 Esperion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and discovers biopharmaceutical products | Health Technology |
ABIONYX Pharma SA
 ABIONYX Pharma SA Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes novel HDL therapies for the treatment of cardiovascular and metabolic diseases | Health Technology |
Politehnica University of Bucharest
 Politehnica University of Bucharest Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Gemphire Therapeutics, Inc.
 Gemphire Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapies for the treatment of Dyslipidemia | Health Technology |
BioSavita, Inc.
 BioSavita, Inc. BiotechnologyHealth Technology Develops novel biological drugs and vaccines | Health Technology |
Ocuphire Pharma, Inc.
 Ocuphire Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceuticals for eye disorders | Health Technology |
Creative Pharma Advisors LLC |
